Rheumatoid Arthritis Devices Market

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that primarily affects the lining of the synovial joints and is associated with progressive disability, premature death, and socioeconomic burdens.the implantable joint prostheses segment accounted for the largest share of the total rheumatoid arthritis market, whereas the spinal devices segment expected to witness double-digit growth rate in the coming years.

Rheumatoid Arthritis Devices Market contains market size and forecasts of Rheumatoid Arthritis Devices in global, including the following market information:

Global Rheumatoid Arthritis Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Rheumatoid Arthritis Devices Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Rheumatoid Arthritis Devices companies in 2021 (%)

The global Rheumatoid Arthritis Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Implantable Joint Prostheses Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Rheumatoid Arthritis Devices include Active Implants LLC, Anika Therapeutics, Inc., Arthrex, Inc., Asahi Kasei Pharma Corporation, B. Braun Melsungen AG, CONMED Corporation, EMulate Therapeutics, Inc. (Nativis, Inc.), Integra Lifesciences Corporation and Johnson & Johnson (DePuy Synthes Inc.), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rheumatoid Arthritis Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Rheumatoid Arthritis Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Rheumatoid Arthritis Devices Market Segment Percentages, by Type, 2021 (%)

Implantable Joint Prostheses

Spinal Devices

Other

Global Rheumatoid Arthritis Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Rheumatoid Arthritis Devices Market Segment Percentages, by Application, 2021 (%)

Elderly

Young adults

Global Rheumatoid Arthritis Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Rheumatoid Arthritis Devices Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Rheumatoid Arthritis Devices revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Rheumatoid Arthritis Devices revenues share in global market, 2021 (%)

Key companies Rheumatoid Arthritis Devices sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Rheumatoid Arthritis Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Active Implants LLC

Anika Therapeutics, Inc.

Arthrex, Inc.

Asahi Kasei Pharma Corporation

B. Braun Melsungen AG

CONMED Corporation

EMulate Therapeutics, Inc. (Nativis, Inc.)

Integra Lifesciences Corporation

Johnson & Johnson (DePuy Synthes Inc.)

Novartis AG

RTI Surgical, Inc.

Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)

Setpoint Medical Corporation

Smith & Nephew plc (Osiris Therapeutics, Inc.)

Stryker Corporation (OrthoSpace Ltd.)

UCB Pharma S.A.

Zimmer Biomet